Literature DB >> 16801342

World Health Organization cancer priorities in developing countries.

T Ngoma1.   

Abstract

The burden of cancer in developing countries is growing and threatens to exact a heavy morbidity, mortality, and economic cost in these countries in the next 20 years. The unfolding global public health dimensions of the cancer pandemic demand a widespread effective international response. The good news is that the majority of cancers in developing countries are preventable, and the efficacy of treatment can be improved with early detection. Currently, the knowledge exists to implement sound, evidence-based practices in cancer prevention, screening/early detection, treatment, and palliation. It is estimated that the information at hand could prevent up to one-third of new cancers and increase survival for another one-third of cancers detected at an early stage. To achieve this, knowledge must be translated into action. To facilitate the call to action in the fight against cancer, the World Health Organization (WHO) has developed a comprehensive approach to cancer control. The WHO has produced many valuable guidelines and resources for the effective implementation of national cancer control programs. Several milestones in the WHO's efforts include the Framework Convention for Tobacco Control, and global strategies for diet and exercise, reproductive health, and cervical cancer. This review examines the strategies and approaches that have successfully resulted into global action to confront the rising global burden of cancer in the developing world.

Entities:  

Mesh:

Year:  2006        PMID: 16801342     DOI: 10.1093/annonc/mdl982

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  25 in total

1.  Pakistani urban population demonstrates a poor knowledge about cancers: a pilot survey.

Authors:  Samia Mazahir; Rabeeya Nusrat; Munira Bokutz; Nida Butool Rizvi; Nadeem Nooruddin Jaffer; Rabia Malik; Kanwal Aliraza Merchant; Ali Raza; Maria Maqsood; Syed Faridul Hasnain; Muhammad Rizwanulhaq Khawaja
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

Review 2.  Bringing cancer care to the poor: experiences from Rwanda.

Authors:  Lawrence N Shulman; Tharcisse Mpunga; Neo Tapela; Claire M Wagner; Temidayo Fadelu; Agnes Binagwaho
Journal:  Nat Rev Cancer       Date:  2014-10-30       Impact factor: 60.716

3.  Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan.

Authors:  H Kim Lyerly; Maria R Fawzy; Zeba Aziz; Reena Nair; C S Pramesh; Vani Parmar; Purvish M Parikh; Rozmin Jamal; Azizunissa Irumnaz; Jun Ren; Martin R Stockler; Amy P Abernethy
Journal:  Oncologist       Date:  2015-04-17

Review 4.  Cancer research: past, present and future.

Authors:  Ya Cao; Ronald A DePinho; Matthias Ernst; Karen Vousden
Journal:  Nat Rev Cancer       Date:  2011-09-15       Impact factor: 60.716

5.  Is cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.

Authors:  Emma Crutchlow; Yohannie Miombe; Tom Latham
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

6.  Breast cancer in developing countries: opportunities for improved survival.

Authors:  Lawrence N Shulman; Walter Willett; Amy Sievers; Felicia M Knaul
Journal:  J Oncol       Date:  2010-12-29       Impact factor: 4.375

7.  Economic Burden of Cancer in Korea during 2000-2010.

Authors:  Kwang-Sig Lee; Hoo-Sun Chang; Sun-Mi Lee; Eun-Cheol Park
Journal:  Cancer Res Treat       Date:  2014-11-24       Impact factor: 4.679

8.  Short view of leukemia diagnosis and treatment in iran.

Authors:  Mehdi Azad; Ramin Bakhshi Biniaz; Mehdi Goudarzi; Naser Mobarra; Shaban Alizadeh; Hajar Nasiri; Ali Dehghani Fard; Saeid Kaviani; Mohamad Hossein Moghadasi; Mohammad Reza Sarookhani; Mousa Vatanmakan; Mehdi Sahmani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-04-01

9.  Clinical preventive services in Guatemala: a cross-sectional survey of internal medicine physicians.

Authors:  Juan E Corral; Lauren D Arnold; Erwin E Argueta; Akshay Ganju; Joaquín Barnoya
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model.

Authors:  Rakesh K Jain; Johanna Lahdenranta; Dai Fukumura
Journal:  PLoS Med       Date:  2008-01-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.